ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1035

Examining the Transcriptional Impact of Liganded ERα in the Inflammatory Milieu of Systemic Lupus Erythematosus

Mara Lennard Richard1, Melissa Cunningham 2, Betty Tsao 3 and Gary Gilkeson 4, 1Medical University of South Carolina, Charleston, SC, 2Medical University of South Carolina, Charleston, 3Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., Charleston, 4Division of Rheumatology & Immunology/Ralph H. Johnson VA Medical Center/Medical University of South Carolina, Charleston, SC

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: ERa, rna-seq and African-Americans, Systemic lupus erythematosus (SLE), transcriptional regulation

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: SLE – Etiology & Pathogenesis Poster I

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic lupus erythematosus (SLE) disproportionally affects females (9:1) over males. Despite significant research effort, the exact mechanisms behind this compelling sex bias are undefined. Our prior studies demonstrate a significant role for estrogen receptor alpha (ERα) mediated inflammation in the pathogenesis of disease. NZM2410 lupus prone mice, expressing a truncated ERα functional knockout, survived longer and had significantly reduced renal disease. Yet, a complete knockout of ERα was not protective, suggesting the truncated isoform may be protective with the full-length gene necessary for disease.

Methods: Our goal is to identify the molecular mechanisms utilized by liganded ERα in regulating the inflammatory milieu. To understand ERα function, transient transfections of full length ERα and a shortened isoform ERα46 (lacking the AF-1 activation domain and similar to the functional knockout) were performed in MDA-MB-231 cells, which lack ERα and mRNA of inflammatory cytokines and cellular proliferation markers examined. Additionally, we identified ERα associated target genes and determined differences in their expression in B cells isolated from female African American (AA) lupus patients with an average age of 45.5 years and matched healthy controls.

Results: Transfection results indicate that both ERα46 reduces ERα66 driven mRNA expression of IL-1β one hour after stimulation with a TLR4 agonist. Similar results were also obtained for the cellular proliferation and survival markers MAPK14 and KLF4. Interestingly, an additive increase in expression was seen for TFF1, another cellular proliferation marker one hour after stimulation. RNA-seq analysis indicates that 60% of ERα associated target genes were differentially expressed between patients and controls. The majority of these genes (82%) were upregulated in lupus patients compared to controls. Genes with increased expression were included TLRs, NFκB related transcription factors and IL-1β.

Conclusion: These results further support a role for ERα in the pathogenesis of SLE. Future goals include utilizing high throughput sequencing technology to examine the transcriptional impact of liganded ERα in B cells of African American pediatric lupus patients.


Disclosure: M. Lennard Richard, None; M. Cunningham, None; B. Tsao, None; G. Gilkeson, None.

To cite this abstract in AMA style:

Lennard Richard M, Cunningham M, Tsao B, Gilkeson G. Examining the Transcriptional Impact of Liganded ERα in the Inflammatory Milieu of Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/examining-the-transcriptional-impact-of-liganded-er%ce%b1-in-the-inflammatory-milieu-of-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/examining-the-transcriptional-impact-of-liganded-er%ce%b1-in-the-inflammatory-milieu-of-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology